Ruedi Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-23
Closed -$2.12K 254
2023
Q1
$2.12K Hold
23
﹤0.01% 220
2022
Q4
$2.09K Buy
+23
New +$1.94K ﹤0.01% 207

Other funds holding NVS

Ruedi Wealth Management's NVS Position: Q2 2023 in Review

Ruedi Wealth Management sold out of Novartis (NVS) in Q2 2023, closing a stake of 23 shares — an estimated $2.12K sold.

Ruedi Wealth Management first reported a position in NVS in Q4 2022 and held it in 2 quarters. The position peaked at $2.12K in Q1 2023. 1,202 funds tracked by Wall St. Rank hold NVS as of Q2 2023.

  • Ruedi Wealth Management reported no remaining Novartis position as of Q2 2023 after selling out during the quarter.
  • Ruedi Wealth Management sold 23 Novartis shares in Q2 2023, an estimated $2.12K.
  • Ruedi Wealth Management first reported a position in Novartis in Q4 2022 and held it in 2 quarters.
  • Ruedi Wealth Management's Novartis position peaked at $2.12K in Q1 2023.
  • 1,202 funds tracked by Wall St. Rank held Novartis as of Q2 2023.

Based on Ruedi Wealth Management's 13F filing for Q2 2023, filed 27 Jul 2023.